- Home
- WVE vs TRS Comparison
WVE vs TRS Comparison
Compare WVE & TRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVE
- TRS
- Stock Information
- Founded
- WVE 2012
- TRS 1986
- Country
- WVE Singapore
- TRS United States
- Employees
- WVE N/A
- TRS N/A
- Industry
- WVE Biotechnology: Pharmaceutical Preparations
- TRS Industrial Specialties
- Sector
- WVE Health Care
- TRS Industrials
- Exchange
- WVE Nasdaq
- TRS Nasdaq
- Market Cap
- WVE 915.6M
- TRS 1.0B
- IPO Year
- WVE 2015
- TRS 2007
- Fundamental
- Price
- WVE $6.95
- TRS $29.97
- Analyst Decision
- WVE Strong Buy
- TRS Strong Buy
- Analyst Count
- WVE 13
- TRS 1
- Target Price
- WVE $20.15
- TRS $40.00
- AVG Volume (30 Days)
- WVE 1.0M
- TRS 441.9K
- Earning Date
- WVE 08-07-2025
- TRS 07-29-2025
- Dividend Yield
- WVE N/A
- TRS 0.53%
- EPS Growth
- WVE N/A
- TRS N/A
- EPS
- WVE N/A
- TRS 0.77
- Revenue
- WVE $104,939,000.00
- TRS $939,580,000.00
- Revenue This Year
- WVE N/A
- TRS $6.37
- Revenue Next Year
- WVE $1.94
- TRS $5.49
- P/E Ratio
- WVE N/A
- TRS $38.91
- Revenue Growth
- WVE N/A
- TRS 3.80
- 52 Week Low
- WVE $5.04
- TRS $19.33
- 52 Week High
- WVE $16.74
- TRS $30.12
- Technical
- Relative Strength Index (RSI)
- WVE 53.71
- TRS 77.01
- Support Level
- WVE $6.25
- TRS $27.53
- Resistance Level
- WVE $7.10
- TRS $30.12
- Average True Range (ATR)
- WVE 0.39
- TRS 0.73
- MACD
- WVE -0.01
- TRS 0.16
- Stochastic Oscillator
- WVE 75.27
- TRS 96.21
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
About TRS TriMas Corporation
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.